Virtual Library

Start Your Search

Seok Kim



Author of

  • +

    P2.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session) (ID 965)

    • Event: WCLC 2018
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
    • +

      P2.16-29 - Clinical Outcomes of Surgically Resected Extraabdominal Chest Wall Desmoid Tumors (ID 13094)

      16:45 - 18:00  |  Presenting Author(s): Seok Kim

      • Abstract

      Background

      Extraabdominal chest wall desmoid tumors are uncommon soft tissue tumors. This study was performed to examine the outcomes of patients with extraabdominal chest wall desmoid tumors and adjacent structures treated with surgery.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      A detailed retrospective clinicopathological study was performed in 17 patients (8 men and 9 women) treated in our institution for extraabdominal desmoid tumors of the chest wall between March 2001 and June 2017. The patients had a median age of 44 years (range, 17-62 years), and the mean pathological diameter of the resected tumors was 92.1mm.

      4c3880bb027f159e801041b1021e88e8 Result

      Complete resection was performed in 13 of the 17 patients (76.5%). One patient had positive microscopic margin and three had gross residual disease. Chest wall reconstruction surgery was necessary in five patients (29%), synthetic patches were used in two patients, muscle flaps in two patients, and a metal plate in one patient. Complications were found in one patient, and there were no cases of operative mortality. Five patients (29%) received postoperative adjuvant therapy (only radiotherapy in three, radiotherapy and chemotherapy in two). Follow-up was complete in all patients and ranged from 9 to 202 months (median 76 months). One of the three patients with gross residual disease showed no change in tumor size during the 114 month follow-up period. Recurrences were found in five patients (29%), four of whom were treated by surgery. Second or more operations were performed in three of these patients. All sites of recurrence were around structures the first resected tumors. The mean recurrence time was 20.8 months after surgery.

      8eea62084ca7e541d918e823422bd82e Conclusion

      Desmoid tumors of the chest wall are locally aggressive tumors with a high recurrence rate. Surgical treatment requires wide radical resection. Multicentric and long-term investigations would be helpful for management of desmoid tumors because of the low prevalence rate of this disease.

      6f8b794f3246b0c1e1780bb4d4d5dc53

  • +

    P3.01 - Advanced NSCLC (Not CME Accredited Session) (ID 967)

    • Event: WCLC 2018
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
    • +

      P3.01-77 - Clinical Characteristics of Korean Lung Cancer Patients with Programmed Death-Ligand 1 Expression (ID 12770)

      12:00 - 13:30  |  Author(s): Seok Kim

      • Abstract
      • Slides

      Background

      Programmed death-ligand 1 (PD-L1) is a transmembrane protein that binds to the programmed death-1 (PD-1) receptor and anti-PD-1 therapy enables the immune response against tumors. The aim of this study was to assess the clinical and pathologic characteristics of PD-L1 positive lung cancer patients in Korea. And we examined correlation between immunohistochemical assays.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      We retrospectively reviewed the clinical and pathologic data of pathologically proven lung cancer patients, and collected 267 cases of formalin-fixed, paraffin-embedded tissue sample from single institution. PD-L1 expression was detected by qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1, Clone 22C3. PD-L1 protein expression is determined by using Tumor Proportion Score (TPS), which is the percentage of viable tumor cells showing partial or complete membrane staining. We categorized according to the percentage of TPS; more than 1% or more than 50%. Among 267 patients, 34 were analyzed by both 22C3 and SP263 assays. We examined the concordance correlation between IHC assays.

      4c3880bb027f159e801041b1021e88e8 Result

      A total of 267 patients were enrolled and major histologic types were adenocarcinoma (69.3%). The majority was smoker (67.4%) and clinical stage IV (60.7%). Thirty one (11.6%) cases of EGFR mutation and 17 (6.4%) cases of ALK FISH positive were included. The patients who showed TPS ≥ 1% and 50% were 116 (42%) and 58 (21%), respectively. More than 1% of TPS group was consisted of adenocarcinoma (67.8%), squamous cell carcinoma (29.6%), and small cell carcinoma (1.9%) histology. And more than 50% of TPS group was composed of adenocarcinoma (72.4%), squamous cell carcinoma (22.4%). More than 1% of TPS group was significantly older than less than 1% of TPS group (64.83 ± 9.38 vs. 61.73 ± 10.78 years, p=0.014). The rate of poorly differentiated pathology was significantly higher in TPS ≥ 1% group (40.8% vs. 25.8%) and TPS ≥ 50% group (53.2% vs. 27.2%). There was no difference in smoking, EGFR mutation, ALK rearrangement status or biopsy site. Among 34 patients analyzed by both 22C3 and SP 263, 27 patients showed positive by both 22C3 and SP263, at the cut-off of 1% or higher. The concordance correlation coefficient was 0.826 (95% confidence interval: 0.736-0.916).

      8eea62084ca7e541d918e823422bd82e Conclusion

      In Korean lung cancer patients, PD-L1 positive group defined as TPS ≥ 1% was older than negative group. And major histology was poorly differentiated non-small cell lung cancer in both TPS ≥ 1% and 50% groups. And our results showed a high correlation between PD-L1 IHC expression data analyzed by 22C3 and SP263 assays.

      6f8b794f3246b0c1e1780bb4d4d5dc53

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.